Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
The study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free surviva…
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
Estimated
~$10 – $6,250
St. Jude Children's Research HospitalNCT06239272
Observational
Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)
This clinical trial evaluates the effect of radiotherapy doses based on tumor size and tumor-specific characteristics (biologically-adapted) in treating patien…
Ewing SarcomaRound Cell Sarcoma With EWSR1-non-ETS Fusion
Estimated
~$10 – $6,250
Mayo ClinicNCT07188532